Quantitative assessment of PSMA PET response to therapy in castration-sensitive prostate cancer using an automated imaging platform for disease identification and measurement

RATIONALE: Prostate cancer treatment response may be automatically quantified using a molecular imaging analysis platform targeting prostate-specific membrane antigen (PSMA). METHODS: A retrospective analysis of patients with castration-sensitive prostate cancer who underwent PSMA-targeted molecular...

Descripción completa

Detalles Bibliográficos
Autores principales: Duriseti, Sai, Berenji, Gholam, Tsai, Sonny, Rettig, Matthew, Nickols, Nicholas G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068685/
https://www.ncbi.nlm.nih.gov/pubmed/37009941
http://dx.doi.org/10.1186/s41824-023-00165-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068685/
https://www.ncbi.nlm.nih.gov/pubmed/37009941
http://dx.doi.org/10.1186/s41824-023-00165-6

Ejemplares similares